Novel Coronavirus Infection (COVID-19) Related Thrombotic and Bleeding Complications in Critically Ill Patients: Experience from an Academic Medical Center.

Thejus T JayakrishnanAaron HaagShane MealyCorbyn MinichAbraham AttahMichael TurkNada AlrifaiLaith AlhuneafatFadi KhouryAdeel NasrullahPatrick WedgeworthMelissa MosleyKirtivardan VashisthaVeli BakalovAbhishek ChaturvediSwathi Sangli

Published in: Journal of clinical medicine (2021)

This study describes a high incidence of thrombotic and bleeding complications among critically ill COVID-19 patients. The findings of thrombotic events in patients on anticoagulation and major bleeding events in patients on no or prophylactic anticoagulation pose a challenging clinical dilemma in the issue of anticoagulation for COVID-19 patients. The questions raised by this study and previous literature on this subject demonstrate that the role of anticoagulation in COVID-19 patients is worthy of further investigation.

Keyphrases

atrial fibrillation
sars cov
end stage renal disease
venous thromboembolism
ejection fraction
newly diagnosed
risk factors
prognostic factors
coronavirus disease
patient reported outcomes